Anti-carcinogenic and anti-metastatic properties of indole-3-carbinol in prostate cancer

Oncology Reports

Volumn 13, Issue 1, 2005, Pages 89-93

  Garikapaty, V P S ^a   Ashok, B T ^a   Chen, Y G ^a   Mittelman, A ^a   Iatropoulos, M ^a   Tiwari, Raj K ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Cell cycle; Copenhagen rat model; Indole 3 carbinol; Primary tumor burden; Therapeutic agent; Tumor metastases

Indexed keywords

3 INDOLEMETHANOL; ANTINEOPLASTIC AGENT; INDOLE DERIVATIVE; INDOLE-3-CARBINOL;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; CELL CULTURE; DISEASE MODEL; LUNG TUMOR; MALE; METASTASIS; PATHOLOGY; PROSTATE TUMOR; RAT; RAT STRAIN;

ANIMALS; ANTICARCINOGENIC AGENTS; DISEASE MODELS, ANIMAL; INDOLES; LUNG NEOPLASMS; MALE; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; RATS; RATS, INBRED STRAINS; TUMOR CELLS, CULTURED;

EID: 21644466433     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.13.1.89     Document Type: Article

References (42)

1. Hocman G: Prevention of cancer: vegetable and plants. Comp Biochem Physiol 93B: 201-212, 1989.
2. Kelloff GJ, Sigma CC and Greenwald P: Cancer chemoprevention: progress and promise. Eur J Cancer 5: 2031-2038, 1999.
3. Kojima T, Tanaka T and Mori H: Chemoprevention of spontaneous endometrial cancer in female Donryu rats by dietary indole-3-carbinol. Cancer Res 54: 1446-1449, 1994. (Pubitemid 24106404)
4. Malloy VL, Bradlow HL and Orentreich N: Interaction between semisynthetic diet and indole-3-carbinol on mammary incidence in Balb/cf C3H mice. Anticancer Res 6D: 4333-4337, 1997. (Pubitemid 28081708)
5. Kim DJ, Lee KK, Han BS, Ann B, Bae JH and Jang JJ: Biphasic modifying effect of indole-3-carbinol on diethylnitrosamine-induced preneoplastic glutathione S-transferase placental form-positive liver cell foci in Sprague-Dawley rats. Jpn J Cancer Res 86: 578-583, 1994. (Pubitemid 24191232)
6. Dashwood RH, Fong AT, Hendricks JD and Bailey GS: Tumor dose-response studies with aflatoxin B1 and the ambivalent modulator indole-3-carbinol: inhibitory versus promotional potency. In: Antimutagenesis and Anticarcinogenesis Mechanisms. Kuroda Y, Shankei DM and Waters MD (eds). Plenum Publishing, New York, NY, pp361-365, 1990.
7. Tanaka T, Mory Y, Morishita Y, Hara A, Ohno T, Kojima T and Mori H: Inhibitory effect of sinigrin and indole-3-carbinol on diethylnitrosamine- induced hepatocarcinogenesis in male ACI/N rats. Carcinogenesis 11: 1403-1406, 1990. (Pubitemid 20245717)
8. Grubbs CJ, Steele VE, Casebolt T, Juliana MM, Eto I, Whitaker LM, Dragnev KH, Kelloff GJ and Lubet RL: Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol. Anticancer Res 15: 709-716, 1995.
9. El-Bayoumy K, Upadhyay P, Desai D, Amin S, Hoffmann D and Wynder EL: Effects of 1,4-phenylenebis(methylene) selenocyanate, phenethylisothiocyanate, indole-3-carbinol and d-limonene individually and in combination on the tumorigenicity of the tobacco-specific nitrosamine 4-(methyl-nitrosamino)-1-(3- pyridyl)-1-butanone in A/J mouse lung. Anticancer Res 16: 2709-2712, 1996. (Pubitemid 26388241)
10. Kelloff GJ, Crowell JA, Steele VE, Lubet RA, Boone CW, Malone WA, Hawk ET and Libermann SO: Progress in cancer chemoprevention. Ann NY Acad Sci 889: 1-13, 1999. (Pubitemid 30040420)
11. Sharma S, Stutzman JD, Kelloff GJ and Steele VE: Screening of potential chemopreventive agents using biochemical markers of carcinogenesis. Cancer Res 54: 5848-5855, 1994. (Pubitemid 24375218)
12. Stresser DM, Bailey GS and Williams DE: Indole-3-carbinol and beta-napthoflavone induction of aflatoxin B1 metabolism and cytochromes P-450 associated with bioactivation and detoxication of aflatoxin B1 in the rat. Drug Metab Dispos 22: 383-391, 1994. (Pubitemid 24158536)
13. Stresser DM, Williams DE, McLellan LI, Harris TM and Bailey GS: Indole-3-carbinol induces a rat liver glutathione transferase subunit (Yc2) with high activity toward aflatoxin B1 exoepoxide. Association with reduced levels of hepatic aflatoxin-DNA adducts in vivo. Drug Metab Dispos 22: 392-399, 1994. (Pubitemid 24158537)
14. Fong AT, Swanson HI, Dashwood RH, William DB, Hendricks JD and Bailey GS: Mechanisms of anti-carcinogenesis by indole-3-carbinol. Biochem Pharmacol 39: 19-26, 1990.
15. Park JY and Bjeldanes LF: Organ selective induction of cytochrome P-450-dependent activities by indole-3-carbinol-derived products: influence on covalent binding of benzo(a) pyrene to hepatic and pulmonary DNA in the rat. Chem Biol Interact 83: 235-247, 1992.
16. Morse MA, LaGreca SD, Amin SG and Chung FL: Effects of indole-3-carbinol on lung tumorigenesis and DNA methylation induced by 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone (NNK) and on the metabolism and disposition of NNK in A/J mice. Cancer Res 50: 2613-2617, 1990. (Pubitemid 20150192)
17. Barrett MC, Clarke HL, Judah DJ, Williamson G and Neal GE: Mechanism of action of dietary chemoprotective agents in rat liver: induction of phase I and II drug metabolizing enzymes and aflatoxin B1 metabolism. Carcinogenesis 18: 1729-1738 1997. (Pubitemid 28134678)
18. Vang O, Frandsa H, Hansen KT, Nielson JB and Anderson O: Modulation of drug metabolizing enzyme expression by condensation products of indole-3-carbinol, an inducer in cruciferous vegetables. Pharmacol Toxicol 84: 59-65, 1999. (Pubitemid 29088365)
19. Jellinck PH, Forkert PG, Riddick DS, Okey AB, Michnovicz JJ and Bradlow HL: Ah receptor binding properties of indolecarbinols and induction of hepatic estradiol hydroxylation. Biochem Pharmacol 45: 1129-1136, 1993. (Pubitemid 23079991)
20. Chen I, McDougal A, Wang F and Safe S: Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane. Carcinogenesis 19: 1631-1639, 1998. (Pubitemid 28441867)
21. Bradlow HL, Michnovicz J, Telang NT and Osborne MP: Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis 12: 1571-1574, 1991.
22. Ashok BT, Chen YG, Liu X, Bradlow HL, Mittelman A and Tiwari RK: Abrogation of estradiol mediated cellular and biochemical effects by indole-3-carbinol. Nutr Cancer 41: 180-187, 2001. (Pubitemid 34666239)
23. Ashok BT, Chen YG, Liu X, Garikapaty VPS, Seplowitz R, Tschorn J, Roy K, Mittelman A and Tiwari RK: Multiple molecular targets of indole-3-carbinol, a chemopreventive anti-estrogen in breast cancer. Eur J Cancer Prev 11: S86-S93, 2002. (Pubitemid 35265867)
24. Grose KR and Bjeldanes LF: Oligomerization of indole-3-carbinol in aqueous acids. Chem Res Toxicol 5: 188-193, 1992.
25. Auborn KJ, Fan S, Rosen EM, Goodwin L, Chandraskaren A, Williams L, Chen D and Carter TH: Indole-3-carbinol is a negative regulator of estrogen. J Nutr 133: 2470S-2475S, 2003. (Pubitemid 36828856)
26. Tiwari RK, Guo L, Bradlow HL, Telang NT and Osborne MP: Selective responsiveness of human breast cancer cells to indole-3-carbinol, a chemopreventive agent. J Natl Cancer Inst 86: 126-131, 1994.
27. Riby JE, Feng C, Chang YC, Schaldach CM, Firestone GL and Bjeldanes LF: The major cyclic trimer product of indole-3-carbinol is a strong agonist of the estrogen receptor signaling pathway. Biochemistry 39: 910-918, 2000. (Pubitemid 30075317)
28. He YH and Schut HA: Inhibition of DNA adduct formation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3-methylimidazo[4,5- f]quinoline by dietary indole-3-carbinol in female rats. J Biochem Mol Toxicol 13: 239-247, 1999.
29. Chen DZ, Qi M, Auborn KJ and Carter TH: Indole-3-carbinol and diindolylmethane induce apoptosis of human cervical cancer cells and in murine HPV16-transgenic preneoplastic cervical epithelium. J Nutr 131: 3294-3302, 2001. (Pubitemid 33136152)
30. Cram EJ, Liu BD, Bjeldanes LF and Firestone GL: Indole-3-carbinol inhibits CDK6 expression in human MCF-7 breast cancer cells by disrupting Sp1 transcription factor interactions with a composite element in the CDK6 gene promoter. J Biol Chem 276: 22332-22340, 2001.
31. Chang YC, Riby J, Chang GH, Peng BC, Firestone G and Bjeldanes LF: Cytostatic and antiestrogenic effects of 2-(indol-3-ylmethyl)-3,3′- diindolylmethane, a major in vivo product of dietary indole-3-carbinol. Biochem Pharmacol 58: 825-834, 1999. (Pubitemid 29329533)
32. Garikapaty VPS, Ashok BT, Chen YG, Mittelman A and Tiwari RK: Anti-androgenic activity of indole-3-carbinol in prostate cancer. Am Ass Cancer Res 45: Abst 2239, 2004.
33. Chinni SR and Sarkar FH: Akt inactivation is a key event in indole-3-carbinol-induced apoptosis in PC-3 cells. Clin Cancer Res 8: 1228-1236, 2002. (Pubitemid 35177379)
34. Waters DJ and Bostwick DG: The canine prostate is a spontaneous model of intraepithelial neoplasia and prostate cancer progression. Anticancer Res 17: 1467-1470, 1997. (Pubitemid 27257635)
35. Cohen LA, Zhao Z, Pittman B and Scimeca J: Effect of soy protein isolate and conjugated linoleic acid on the growth of Dunning R-3327-AT-1 rat prostate tumors. Prostate 54: 169-180, 2003. (Pubitemid 36120314)
36. Yedavelli SP, Guo L, Daou ME, Srivastava PK, Mittelman A and Tiwari RK: Preventive and therapeutic effect of tumor derived heat shock protein, gp96, in an experimental prostate cancer model. Int J Mol Med 4: 243-248, 1999.
37. Hautmann S, Huland E, Wullbrand A, Friedrich M and Huland H: Treatment of metastatic hormone-refractory prostate adenocarcinoma (MatLyLu) in Copenhagen rats with microosmotic interleukin-2 pumps. Anticancer Res 20: 4495-4498, 2000. (Pubitemid 32141809)
38. Wang J, Eltoum IE and Lamartiniere CA: Dietary genistein suppresses chemically induced prostate cancer in Lobund-Wistarrats. Cancer Lett 186: 11-18, 2002. (Pubitemid 35245321)
39. Pollard M and Wolter W: Prevention of spontaneous prostate-related cancer in Lobund-Wistar rats by a soy protein isolate/isoflavone diet. Prostate 45: 101-105, 2000.
40. Pollard M: Prevention of prostate-related cancers in Lobund-Wistarrats. Prostate 39: 305-309, 1999.
41. Martiniello-Wilks R, Dane A, Mortensen E, Jeyakumar G, Wang XY and Russell PJ: Application of the transgenic adenocarcinoma mouse prostate (TRAMP) model for pre-clinical therapeutic studies. Anticancer Res 23: 2633-2642, 2003. (Pubitemid 36897137)
42. Adhami VM, Ahmad N and Mukhtar H: Molecular targets for green tea in prostate cancer prevention. J Nutr 133: 2417S-2424S, 2003. (Pubitemid 36828848)